EP0511726A2 - Arrangement for retaining blister pack tablets - Google Patents
Arrangement for retaining blister pack tablets Download PDFInfo
- Publication number
- EP0511726A2 EP0511726A2 EP92250101A EP92250101A EP0511726A2 EP 0511726 A2 EP0511726 A2 EP 0511726A2 EP 92250101 A EP92250101 A EP 92250101A EP 92250101 A EP92250101 A EP 92250101A EP 0511726 A2 EP0511726 A2 EP 0511726A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- tablets
- blister pack
- cover
- deck
- assembly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003826 tablet Substances 0.000 description 65
- 238000002657 hormone replacement therapy Methods 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 1
- 239000007947 dispensing tablet Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
- B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
- B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
Definitions
- the instant invention relates to containers for tablets, and more particularly, the instant invention relates to containers for retaining, concealing and dispensing tablets arrayed in blister packs and used for purposes such as birth control or hormone replacement therapy (HRT).
- HRT hormone replacement therapy
- birth control or HRT tablets generally requires that the tablets be taken one at a time in a preselected order on a daily basis.
- the tablets are dispensed in accordance with either a 21-day cycle or a 28-day cycle regime. It has been found that utilizing blister packs arranged in seven columns, one for each day, and either three rows or four rows to make up the 21-day or 28-day cycle, provides a satisfactory approach.
- U.S. Patent 4,817,819 is exemplary of an approach to packaging birth control tablets wherein the tablets are mounted on a sleeve which is retained in a tray; however, this approach requires the separate molding and assembly of two parts. Trays which have complex and extensive surface contact with the sleeves or covers in which they are received can upon occasion become jammed since debris can collect in convoluted surfaces.
- the instant invention contemplates an assembly for containing tablets, such as birth control tablets, in an array
- the assembly comprises a blister pack containing a plurality of tablets disposed in an area of the blister pack and configured in a selected array and a container comprising a deck and cover.
- the deck of the container includes a flat surface with a plurality of compartments therethrough, the compartments being arranged to correspond to the selected array of tablets in the blister pack.
- the cover includes a rim portion of an area at least as large as the area of the blister pack and a window portion of an area less than the area of the blister pack and larger than the area of the selected array.
- the cover is secured to the deck with the blister disposed therebetween, wherein the tablets and blister pack are visible and accessible through the window of the cover and the tablets are dispensable through the openings in the deck by pressing on the tablets through the window.
- the container of the assembly is unitary with the deck and cover being formed of one piece.
- the assembly further includes a front lid and a back lid, the front lid being hinged to the cover and the back lid being hinged to the deck.
- a latch is provided for latching the front and back lids to one another sandwiching the blister pack, cover and deck between the lids.
- the instant invention further contemplates utilizing indicating means proximate the window which cooperates with locating means on the blister pack to properly position the blister pack within the container while indicating to the user which tablet in the array should be taken first.
- the indicating means is a lockable cylinder with a day calendar thereon and in accordance with another embodiment the indicating means is a lockable loop with a day calendar thereon.
- blister packs designated generally by the numerals 50a-50k, each of which have twenty-eight compartments 52 therein for receiving tablets, such as birth control or HRT tablets 53, which are taken by a consumer sequentially at a rate of one tablet per day.
- tablets such as birth control or HRT tablets 53
- indicators in the form of arrows 54 between each compartment 52 in a row and arrows 56 connecting the end of one row to the beginning of the next row are provided.
- the rows of compartments 52 contain seven tablet compartments.
- each tablet compartment 52 is numbered while, in Figures 3, 4, 6 and 7, no numbers are used and, in Figures 9 and 10, letters are used.
- Each of the blister packs 50 includes a triangular notch 58 adjacent one edge 59a thereof so as to properly locate the blister pack in its respective container, the opposite edge 59b being alignable in the container for retaining the blister pack.
- Graphics on the blister packs 50a-50k differ in appearance but all have the function of directing the user to sequentially consume the birth control or HRT tablets 53 in the right order. Without proper instruction, the consumer could possibly not follow the correct order by just selecting any tablet or perhaps taking tablets sequentially from the columns, i.e., vertically with respect to Figures 1-10, instead of horizontally. In order to be effective, it is important that the tablets 53 be consumed in the correct sequence.
- the last seven compartments may either be empty or contain non-active tablets.
- Figures 11-17 disclose a first embodiment of the invention wherein a container, designated generally by the numeral 60 has first, second, third and fourth panels 62, 64, 66 and 68, respectively.
- panel 62 is joined to panel 64 via a living hinge 70;
- panel 64 is joined to panel 66 via a living hinge 72;
- panel 66 is joined to panel 68 via a living hinge 74.
- Figures 11 and 12 are front and rear views, respectively, showing the container 60 closed with the panels 62-68 folded upon one another accordion fashion in the manner of Figure 17 to collapse as is illustrated in Figure 13.
- the first panel 62 has an array of concave depressions 76 therein when viewed from the inside as in Figures 15 and 16 which appear as convex domes 78 on the outside surface thereof as in Figures 11, 13, 14 and 17.
- the front cover formed by the first panel 62 has a lip 80 projecting therefrom which has a hooked end 82 adapted to snap over an edge 84 ( Figure 15) on the fourth panel 68.
- the fourth panel 68 has a lip 86 with a hook 88 adapted to snap over an edge 90 of the first panel 62 so as to further hold the panels 62 and 68 superimposed with the second and third panels 64 and 66 sandwiched or folded therebetween.
- a selected one of the blister packs 50 of Figures 1-10 is sandwiched between the second and third panels 64 and 66, respectively, with the tablets 53 facing through a window 92 defined by a rim 93 which comprises the second panel 64.
- the third panel 66 forms a deck for supporting the blister pack 50 and has an array of twenty-eight openings 94 corresponding to the compartments 52 in the blister pack which hold the birth control tablets 53. Since the tablets 53 are exposed through the window 92 and the blister pack 50 is retained behind the back surface of the panel 64, the tablets may be popped out by pressing the tablets from the front side of the blister pack to pop the tablets through openings 94 in the third panel 66 which forms the deck for supporting the blister pack.
- the second panel 64 has a V-shaped area 96 which is raised in the front view of Figures 15 and 16. Preferably, the word "START" is printed on the raised surface of the indicator 96.
- While the third panel 66 has a raised indicator portion 98 which corresponds in shape to the recessed indicator portion 96 and registers with the notch 58 at the edge 59a of pack 50.
- a lip 100 projecting from the back surface of the panel 64 as is shown in Figure 14 engages the edge 59b of the blister pack 50 mounted between the panels 66 and 64 so as to cooperate with the raised indicator 98 to hold the blister pack in place.
- a slot 102 is placed in the second panel 64 and a strip 104, preferably a continuous loop 105 (Fig. 39), with the days of the week is placed in a recessed area 106 in the fourth panel 68 so as to be visible through the slot 102 when the container 60 is folded accordion fashion so as to close as is shown in Figures 13 and 17.
- the continuous loop 105 has thirteen or more days thereon so that the starting day can be easily selected by the patient.
- a locking detent 107 locks into recesses 108 in the loop 105 to prevent the loop from being moved after a starting day has been selected.
- Container 60 is used as is shown in Figure 16 wherein when the panel 62 is pivoted from its Figure 12 to its Figure 16 position the tablets 53 are exposed through the window 92 for dispensing from the blister pack 50. As the tablets 53 are sequentially pressed, they rupture the back surface of the blister pack 50 and pass through the openings 94 in the third panel 66 which is exposed by rotating the fourth panel 68 which forms the rear cover of container 60 to an open position.
- FIG. 11-17 provides a birth control container 60 which conceals the nature of the tablets 53 being dispensed by covering both the front and back side of the blister pack 50. Moreover, the container 60 is fabricated as a unitary, one-piece structure which is folded in a manner readily apparent to the user to perform its function of containing and concealing the blister pack 50.
- the second embodiment of the container designated generally by the numeral 60a, is a four-panel container similar to the four-panel container of Figures 11-17, with the exception that the first or front panel 62a has planar inside and outside surfaces 110 and 112, respectively, instead of having the convex bumps 78 appearing on the outer surface 110 as is the case in the container 60 of Figures 11-17.
- This is accomplished by providing the first panel 62a, which is the front cover, with a relatively wide pair of side edge flanges 114 (Fig. 20) so that when the cover is closed, as in Figure 20, the tablets 53 are concealed behind the side flanges 114.
- the remainder of the container has a structural configuration substantially identical to that of the first embodiment of Figures 11-17.
- a container, designated generally by numeral 120 comprises only two panels, front panel 122 and a rear panel 124.
- first and fourth panels 62 and 68 are dispensed with so that the tablets 53 are always visible.
- the tablets 53 are individually exposed through the openings 126 in the rear panel 124.
- the blister pack 50 is sandwiched between the front cover 122 and the rear cover 124 with the front cover having a lip 126 which latches over the edge 128 of the rear cover and the rear cover having a lip 130 which latches over the edge 132 of the front cover.
- the fourth embodiment of the invention has a structure substantially identical to the third embodiment; however, in the fourth embodiment, the front panel 122a and rear panel 124a of container 120 are of transparent plastic rather than opaque plastic.
- the indicator 96 is configured by having the word "START" placed on the raised triangular area 96 on front panel 122a (see Figure 30).
- the raised triangular area 134 is opaque so that it is visible through the corresponding transparent raised triangular area 136 of the front cover 122a.
- the blister pack 50 is opaque so the raised area 134, which is preferably of a contrasting color to the blister pack, is highlighted to emphasize where the dosage starts by pointing to the "first tablet" 53 in the array of tablets.
- the fifth embodiment of the tablet container is essentially similar to the third and fourth embodiments in which the blister pack 50 is retained between a front cover 122b and a rear cover 124b; however, in the fifth embodiment, a cylindrical calendar retainer 141 is disposed in proximity with the hinge 72b which connects the front cover 122b to the rear cover 124b. Disposed in the circular calendar retainer 141 is a cylindrical calendar, designated generally by the numeral 142, which has seven daily calendars 144 disposed around and extending axially along its surface. Each daily calendar 144 starts with a new day and can be selectively dialed into registration with a window 146 by rotating a knurled knob 148 on the end of the cylinder 142. Means are provided to fix the cylinder 142 in place so that it can not be readily rotated after being set for one cycle.
- calendar retainer 141 is formed by a pair of cooperating cylinder halves 150 and 152 formed in the front and rear covers 122b and 124b, respectively.
- the cylindrical calendar 142 is retained in the thus formed cylindrical calendar retainer 140.
- the cylinder halves 150 and 152 each have semi-annular shoulder 154 and 156, respectively, which close around a reduced diameter portion 158 (Fig. 31) of the cylindrical calendar 142.
- the tablet container 140 is substantially similar to the tablet container 120, with similar reference numerals identifying substantially similar structure.
- the calendar cylinder 142 or the loop 105 has the days Saturday 143 and Sunday 145 highlighted or shaded in a color different from the other days to assist the user in coordinating her cycle with her weekly schedule.
- the blister pack container 120, 120a and 140 of Figures 24 - 35 each have blister packs 50 which are readily visible.
- the containers 120, 120a and 140 may be carried in a plastic retainer 162 resembling a wallet or business card holder which has a pocket 164 for retaining the container formed in a back flap 166 of the retainer.
- the container 120, 120a or 140 is then concealed by a front flap 168 hinged to the back flap 166.
- the plastic retainer 162 may, of course, also be used to carry the four panel tablet containers 60 and 60a.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
- Control And Other Processes For Unpacking Of Materials (AREA)
Abstract
Description
- The instant invention relates to containers for tablets, and more particularly, the instant invention relates to containers for retaining, concealing and dispensing tablets arrayed in blister packs and used for purposes such as birth control or hormone replacement therapy (HRT).
- The utilization of birth control or HRT tablets generally requires that the tablets be taken one at a time in a preselected order on a daily basis. The tablets are dispensed in accordance with either a 21-day cycle or a 28-day cycle regime. It has been found that utilizing blister packs arranged in seven columns, one for each day, and either three rows or four rows to make up the 21-day or 28-day cycle, provides a satisfactory approach.
- Since the blister packs may be carried around by the user, it is necessary to protect the tablets in the blister pack from damage which may occur over the cycle. This need has resulted in numerous arrangements for retaining blister packs. Many of the prior art packages for retaining birth control blister packs are relatively complex and expensive to manufacture in that they have somewhat elaborate latches and hinges. Moreover, they may from time to time become jammed. These devices are exemplified by the dial type of container disclosed in U.S. Pat. No. 4,165,709. The operation of these dial-type dispensers may not be readily apparent to all users and from time to time mistakes are made in dispensing the tablets due to the complexity of these dispensers. Other types of tablet containers using oval or circular arrangements are exemplified by the containers of U.S. Pat. Nos. 3,283,885 and 4,165,709.
- As exemplified perhaps by U.S. Pat. Nos. 3,677,397 and 3,504,788 there are several tablet containers for birth control tablets which have flexible covers. These particular arrangements do not adequately protect the tablets in that pressure applied to the covers can damage the tablets or cause the tablets to be inadvertently dispensed through the trays upon which they are mounted. In order to avoid this, many commercial containers have domed covers.
- U.S. Patent 4,817,819 is exemplary of an approach to packaging birth control tablets wherein the tablets are mounted on a sleeve which is retained in a tray; however, this approach requires the separate molding and assembly of two parts. Trays which have complex and extensive surface contact with the sleeves or covers in which they are received can upon occasion become jammed since debris can collect in convoluted surfaces.
- U.S. Pat. Nos. 3,527,190; 3,584,598; 3,579,883; 3,587,517 and 3,630,171 are illustrative of tablet containers which utilize hinged covers. In the past, containers using hinged covers have been relatively expensive in that they require both difficult to configure hinges and latches. These parts must be carefully molded and are subject to wear and breakage. Moreover, when these containers have compartments for dispensed tablets, the tablets tend to become jammed in the compartments. Accordingly, prior art containers utilizing hinged covers have several drawbacks.
- In view of the aforementioned considerations, there is a need for containers for tablets such as blister packaged birth control tablets, which containers do not have drawbacks such as the drawbacks of the aforediscussed patents. Moreover, there is a need for such containers wherein the container has the general appearance of a discreet cosmetic item.
- It is an object of the instant invention to provide new and improved containers for storing and dispensing supplies of tablets, such as birth control tablets, which must be dispensed during a preselected cycle.
- Upon further study of the specification and appended claims, further objects and advantages of this invention will become apparent to those skilled in the art.
- In view of the aforementioned object and other objects, the instant invention contemplates an assembly for containing tablets, such as birth control tablets, in an array wherein the assembly comprises a blister pack containing a plurality of tablets disposed in an area of the blister pack and configured in a selected array and a container comprising a deck and cover. The deck of the container includes a flat surface with a plurality of compartments therethrough, the compartments being arranged to correspond to the selected array of tablets in the blister pack. The cover includes a rim portion of an area at least as large as the area of the blister pack and a window portion of an area less than the area of the blister pack and larger than the area of the selected array. The cover is secured to the deck with the blister disposed therebetween, wherein the tablets and blister pack are visible and accessible through the window of the cover and the tablets are dispensable through the openings in the deck by pressing on the tablets through the window.
- In accordance with the preferred embodiment of the invention, the container of the assembly is unitary with the deck and cover being formed of one piece.
- In accordance with a further embodiment of the invention, the assembly further includes a front lid and a back lid, the front lid being hinged to the cover and the back lid being hinged to the deck. A latch is provided for latching the front and back lids to one another sandwiching the blister pack, cover and deck between the lids.
- The instant invention further contemplates utilizing indicating means proximate the window which cooperates with locating means on the blister pack to properly position the blister pack within the container while indicating to the user which tablet in the array should be taken first. In accordance with one embodiment, the indicating means is a lockable cylinder with a day calendar thereon and in accordance with another embodiment the indicating means is a lockable loop with a day calendar thereon.
- Various other objects, features and attendant advantages of the present invention will be more fully appreciated as the same becomes better understood when considered in conjunction with the accompanying drawings in which like reference characters designate the same or similar parts throughout the several views, and wherein:
- Figures 1-10 are top views of blister packs showing various arrangements for indicating the order in which an array of tablets, such as birth control or HRT tablets, should be taken;
- Figure 11 is a planar view of the front of a first embodiment of a container for one of the blister packs shown in Figures 1-10;
- Figure 12 is a planar view of the rear of the container of Figure 11;
- Figure 13 is a side view of the container of Figures 11 and 12;
- Figure 14 is a side view of the container of Figures 11-13, but shown unfolded;
- Figure 15 is a front planar view of a container of Figures 11-13 shown unfolded;
- Figure 16 is a front view of the container of Figures 11-13 showing the front cover opened to expose for use an array of tablets on an inserted blister pack;
- Figure 17 is a side view of the container of Figures 11-13 showing how the blister pack is sandwiched within the container;
- Figure 18 is a front planar view of a second embodiment of a blister pack container in accordance with the instant invention;
- Figure 19 is a rear view of the container of Figure 18;
- Figure 20 is a side view of the container of Figures 18 and 19;
- Figure 21 is a side view of the container of Figures 18-20 but showing the container unfolded;
- Figure 22 is a front planar view showing the container of Figures 18-20 opened to access birth control tablets on a blister pack therein;
- Figure 23 is a side view showing how a blister pack of tablets is sandwiched in the container of Figures 18-22 as the container and blister pack are assembled and folded;
- Figure 24 is a top view of the third embodiment of a blister pack container for tablets retained in a blister pack;
- Figure 25 is a side view of the container of Figure 24;
- Figure 26 is a front view showing the container of Figure 24 opened to receive a blister pack;
- Figure 27 is a side view of the opened container of Figure 26;
- Figure 28 is a side view showing how a blister pack is retained between front and rear covers of the container of Figures 24-27;
- Figure 29 is a front planar view of a fourth embodiment of the invention showing a transparent blister pack container having a structure similar to the container of Figures 24-28;
- Figure 30 is a view of the transparent container of Figure 29 shown open for receiving a blister pack;
- Figure 31 is a front planar view of a blister pack container according to a fifth embodiment of the invention wherein a calendar wheel is used;
- Figure 32 is a side view of the container of Figure 31;
- Figure 33 is a side view of the container of Figures 31 and 32 shown opened up;
- Figure 34 is a back view of the container of Figures 31 and 32 shown opened up;
- Figure 35 is a front or inside surface view of the container of Figure 31 and 32 shown opened up;
- Figure 36 is an end view of the container of Figure 31 taken from the opposite end of Figure 32;
- Figure 37 is a planar view of the container of Figures 24-36 stored in a holder;
- Figure 38 is a perspective view of the holder of Figure 37; and
- Figure 39 is a perspective view of a loop-type calendar band with a locking detent.
- Referring now to Figures 1-10, there are shown blister packs designated generally by the numerals 50a-50k, each of which have twenty-eight
compartments 52 therein for receiving tablets, such as birth control orHRT tablets 53, which are taken by a consumer sequentially at a rate of one tablet per day. In order to avoid confusion, indicators in the form ofarrows 54 between eachcompartment 52 in a row andarrows 56 connecting the end of one row to the beginning of the next row are provided. In the illustrated embodiment, the rows ofcompartments 52 contain seven tablet compartments. There are four rows oftablet compartments 52 to provide for a twenty-eight day cycle. In the embodiments of Figures 1, 2, 5 and 8, eachtablet compartment 52 is numbered while, in Figures 3, 4, 6 and 7, no numbers are used and, in Figures 9 and 10, letters are used. Each of the blister packs 50 includes atriangular notch 58 adjacent oneedge 59a thereof so as to properly locate the blister pack in its respective container, theopposite edge 59b being alignable in the container for retaining the blister pack. - Graphics on the blister packs 50a-50k differ in appearance but all have the function of directing the user to sequentially consume the birth control or
HRT tablets 53 in the right order. Without proper instruction, the consumer could possibly not follow the correct order by just selecting any tablet or perhaps taking tablets sequentially from the columns, i.e., vertically with respect to Figures 1-10, instead of horizontally. In order to be effective, it is important that thetablets 53 be consumed in the correct sequence. - Since dosages for HRT tablets may be for a 21 instead of a 28 day cycle, the last seven compartments may either be empty or contain non-active tablets.
- Figures 11-17 disclose a first embodiment of the invention wherein a container, designated generally by the numeral 60 has first, second, third and
fourth panels panel 62 is joined topanel 64 via aliving hinge 70;panel 64 is joined topanel 66 via aliving hinge 72; andpanel 66 is joined topanel 68 via aliving hinge 74. Figures 11 and 12 are front and rear views, respectively, showing thecontainer 60 closed with the panels 62-68 folded upon one another accordion fashion in the manner of Figure 17 to collapse as is illustrated in Figure 13. - The
first panel 62 has an array ofconcave depressions 76 therein when viewed from the inside as in Figures 15 and 16 which appear asconvex domes 78 on the outside surface thereof as in Figures 11, 13, 14 and 17. As is best seen in Figures 14 and 17, the front cover formed by thefirst panel 62 has alip 80 projecting therefrom which has a hookedend 82 adapted to snap over an edge 84 (Figure 15) on thefourth panel 68. Conversely, thefourth panel 68 has alip 86 with ahook 88 adapted to snap over anedge 90 of thefirst panel 62 so as to further hold thepanels third panels - A selected one of the blister packs 50 of Figures 1-10 is sandwiched between the second and
third panels tablets 53 facing through awindow 92 defined by arim 93 which comprises thesecond panel 64. Thethird panel 66 forms a deck for supporting theblister pack 50 and has an array of twenty-eightopenings 94 corresponding to thecompartments 52 in the blister pack which hold thebirth control tablets 53. Since thetablets 53 are exposed through thewindow 92 and theblister pack 50 is retained behind the back surface of thepanel 64, the tablets may be popped out by pressing the tablets from the front side of the blister pack to pop the tablets throughopenings 94 in thethird panel 66 which forms the deck for supporting the blister pack. Thesecond panel 64 has a V-shapedarea 96 which is raised in the front view of Figures 15 and 16. Preferably, the word "START" is printed on the raised surface of theindicator 96. - While the
third panel 66 has a raisedindicator portion 98 which corresponds in shape to the recessedindicator portion 96 and registers with thenotch 58 at theedge 59a ofpack 50. Alip 100 projecting from the back surface of thepanel 64 as is shown in Figure 14 engages theedge 59b of theblister pack 50 mounted between thepanels indicator 98 to hold the blister pack in place. - As is seen in Figures 15 and 16, in order to provide an indicator for the day of the week, a
slot 102 is placed in thesecond panel 64 and astrip 104, preferably a continuous loop 105 (Fig. 39), with the days of the week is placed in a recessedarea 106 in thefourth panel 68 so as to be visible through theslot 102 when thecontainer 60 is folded accordion fashion so as to close as is shown in Figures 13 and 17. Thecontinuous loop 105 has thirteen or more days thereon so that the starting day can be easily selected by the patient. Alocking detent 107 locks intorecesses 108 in theloop 105 to prevent the loop from being moved after a starting day has been selected. -
Container 60 is used as is shown in Figure 16 wherein when thepanel 62 is pivoted from its Figure 12 to its Figure 16 position thetablets 53 are exposed through thewindow 92 for dispensing from theblister pack 50. As thetablets 53 are sequentially pressed, they rupture the back surface of theblister pack 50 and pass through theopenings 94 in thethird panel 66 which is exposed by rotating thefourth panel 68 which forms the rear cover ofcontainer 60 to an open position. - The arrangement of Figures 11-17 provides a
birth control container 60 which conceals the nature of thetablets 53 being dispensed by covering both the front and back side of theblister pack 50. Moreover, thecontainer 60 is fabricated as a unitary, one-piece structure which is folded in a manner readily apparent to the user to perform its function of containing and concealing theblister pack 50. - The second embodiment of the container, designated generally by the numeral 60a, is a four-panel container similar to the four-panel container of Figures 11-17, with the exception that the first or
front panel 62a has planar inside and outsidesurfaces convex bumps 78 appearing on theouter surface 110 as is the case in thecontainer 60 of Figures 11-17. This is accomplished by providing thefirst panel 62a, which is the front cover, with a relatively wide pair of side edge flanges 114 (Fig. 20) so that when the cover is closed, as in Figure 20, thetablets 53 are concealed behind theside flanges 114. Other than redimensioning the components, especially the height of theside walls 114 of thefirst panel 62a forming the front cover of thecontainer 60a, the remainder of the container has a structural configuration substantially identical to that of the first embodiment of Figures 11-17. - In the third embodiment, a container, designated generally by
numeral 120 comprises only two panels,front panel 122 and arear panel 124. In the third embodiment, first andfourth panels tablets 53 are always visible. As is seen in Figure 24, there is no front cover over theblister pack 50 and as is seen in Figure 25, thetablets 53 are individually exposed through theopenings 126 in therear panel 124. As in the first and second embodiments, theblister pack 50 is sandwiched between thefront cover 122 and therear cover 124 with the front cover having alip 126 which latches over theedge 128 of the rear cover and the rear cover having alip 130 which latches over theedge 132 of the front cover. - The remaining elements having reference numerals similar to the reference numerals of Figures 1-23 are similar structures functioning in similar ways.
- The fourth embodiment of the invention has a structure substantially identical to the third embodiment; however, in the fourth embodiment, the
front panel 122a and rear panel 124a ofcontainer 120 are of transparent plastic rather than opaque plastic. Theindicator 96 is configured by having the word "START" placed on the raisedtriangular area 96 onfront panel 122a (see Figure 30). - In another embodiment, the raised
triangular area 134 is opaque so that it is visible through the corresponding transparent raised triangular area 136 of thefront cover 122a. Theblister pack 50 is opaque so the raisedarea 134, which is preferably of a contrasting color to the blister pack, is highlighted to emphasize where the dosage starts by pointing to the "first tablet" 53 in the array of tablets. - The fifth embodiment of the tablet container, designated generally by the numeral 140, is essentially similar to the third and fourth embodiments in which the
blister pack 50 is retained between afront cover 122b and arear cover 124b; however, in the fifth embodiment, acylindrical calendar retainer 141 is disposed in proximity with thehinge 72b which connects thefront cover 122b to therear cover 124b. Disposed in thecircular calendar retainer 141 is a cylindrical calendar, designated generally by the numeral 142, which has sevendaily calendars 144 disposed around and extending axially along its surface. Eachdaily calendar 144 starts with a new day and can be selectively dialed into registration with awindow 146 by rotating aknurled knob 148 on the end of thecylinder 142. Means are provided to fix thecylinder 142 in place so that it can not be readily rotated after being set for one cycle. - As is seen in Figures 31, 32 and 35,
calendar retainer 141 is formed by a pair of cooperating cylinder halves 150 and 152 formed in the front andrear covers blister pack 50 therebetween, thecylindrical calendar 142 is retained in the thus formedcylindrical calendar retainer 140. As is seen in Figure 35, the cylinder halves 150 and 152 each havesemi-annular shoulder cylindrical calendar 142. In all other respects, thetablet container 140 is substantially similar to thetablet container 120, with similar reference numerals identifying substantially similar structure. - In accordance with a sixth embodiment of the invention, the
calendar cylinder 142 or theloop 105, depending on which is used, has thedays Saturday 143 andSunday 145 highlighted or shaded in a color different from the other days to assist the user in coordinating her cycle with her weekly schedule. - The
blister pack container blister packs 50 which are readily visible. In order to maintain the users privacy, thecontainers plastic retainer 162 resembling a wallet or business card holder which has apocket 164 for retaining the container formed in aback flap 166 of the retainer. Thecontainer front flap 168 hinged to theback flap 166. If desired, theplastic retainer 162 may, of course, also be used to carry the fourpanel tablet containers - From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69312791A | 1991-04-29 | 1991-04-29 | |
US693127 | 1991-04-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0511726A2 true EP0511726A2 (en) | 1992-11-04 |
EP0511726A3 EP0511726A3 (en) | 1992-12-23 |
EP0511726B1 EP0511726B1 (en) | 1997-07-16 |
Family
ID=24783423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP92250101A Expired - Lifetime EP0511726B1 (en) | 1991-04-29 | 1992-04-29 | Arrangement for retaining blister pack tablets |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0511726B1 (en) |
AT (1) | ATE155340T1 (en) |
CA (1) | CA2067611A1 (en) |
DE (1) | DE69220842T2 (en) |
DK (1) | DK0511726T3 (en) |
ES (1) | ES2107499T3 (en) |
GR (1) | GR3024935T3 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040876A2 (en) * | 1996-04-25 | 1997-11-06 | Alfred Von Schuckmann | Inhaler |
WO2001045636A1 (en) | 1999-12-20 | 2001-06-28 | Merck & Co., Inc. | Pharmaceutical kit |
WO2004087038A1 (en) | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Kit for pharmaceutical use |
US6978894B2 (en) | 1999-12-20 | 2005-12-27 | Merck & Co., Inc. | Blister package for pharmaceutical treatment card |
US7987986B2 (en) | 2007-08-06 | 2011-08-02 | Bayer Schering Pharma Ag | Device and use for storage and provision of medicament wafers |
WO2012083109A1 (en) | 2010-12-17 | 2012-06-21 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10217929A1 (en) * | 2002-04-22 | 2003-11-06 | Sixp Ag | Device for dispensing tablets |
AU2010211258A1 (en) | 2009-02-06 | 2011-09-08 | Bayer Pharma Aktiengesellschaft | Method for the production of a stack of medicament pouches used for storing and supplying medicament wafers, medicament pouch template for producing said stack, and use of the medicament pouch template |
DE102009008027A1 (en) | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Device and use for storage and provision of drug wafers |
DE102009008026A1 (en) | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Method for producing stack of medicament pockets that is utilized for storing and providing medicament wafers for e.g. contraception, involves stacking pockets so that markings are arranged in marking sections of pockets within each stack |
DE102009008028A1 (en) | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Method for manufacturing stack of pharmaceutical foil bag for storing and supplying pharmaceutical wafers for contraception of hormone replacement therapy, involves following one of bags to another bag with markings found at end of edge |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3283885A (en) * | 1963-07-31 | 1966-11-08 | Schering Ag | Package for medicament tablets and the like |
US3530818A (en) * | 1968-08-19 | 1970-09-29 | Lilly Co Eli | Pill dispenser with indicating means |
US3579883A (en) * | 1969-02-24 | 1971-05-25 | Lilly Co Eli | Pill dispenser with indicating means |
US3630171A (en) * | 1969-09-29 | 1971-12-28 | Ortho Pharma Corp | Tablet-dispensing device |
NL8402622A (en) * | 1984-08-29 | 1986-03-17 | Robert Maas | Holder esp. for strip packed contraceptive pills - has indicator strips with day markings corresp. to pill positions, only one marker strip shows first day pill is taken by user |
DE8814793U1 (en) * | 1988-11-28 | 1989-02-23 | Lobermeier, Hans, 6050 Offenbach | Packaging for small-sized goods such as tablets, pills, candies, etc. |
US5082113A (en) * | 1990-05-02 | 1992-01-21 | Romick Jerome M | Unit-dose medication handling and dispensing system with signalling tabs and flap |
-
1992
- 1992-04-29 CA CA002067611A patent/CA2067611A1/en not_active Abandoned
- 1992-04-29 DE DE69220842T patent/DE69220842T2/en not_active Expired - Fee Related
- 1992-04-29 EP EP92250101A patent/EP0511726B1/en not_active Expired - Lifetime
- 1992-04-29 ES ES92250101T patent/ES2107499T3/en not_active Expired - Lifetime
- 1992-04-29 AT AT92250101T patent/ATE155340T1/en not_active IP Right Cessation
- 1992-04-29 DK DK92250101.0T patent/DK0511726T3/en active
-
1997
- 1997-10-03 GR GR970402576T patent/GR3024935T3/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3283885A (en) * | 1963-07-31 | 1966-11-08 | Schering Ag | Package for medicament tablets and the like |
US3530818A (en) * | 1968-08-19 | 1970-09-29 | Lilly Co Eli | Pill dispenser with indicating means |
US3579883A (en) * | 1969-02-24 | 1971-05-25 | Lilly Co Eli | Pill dispenser with indicating means |
US3630171A (en) * | 1969-09-29 | 1971-12-28 | Ortho Pharma Corp | Tablet-dispensing device |
NL8402622A (en) * | 1984-08-29 | 1986-03-17 | Robert Maas | Holder esp. for strip packed contraceptive pills - has indicator strips with day markings corresp. to pill positions, only one marker strip shows first day pill is taken by user |
DE8814793U1 (en) * | 1988-11-28 | 1989-02-23 | Lobermeier, Hans, 6050 Offenbach | Packaging for small-sized goods such as tablets, pills, candies, etc. |
US5082113A (en) * | 1990-05-02 | 1992-01-21 | Romick Jerome M | Unit-dose medication handling and dispensing system with signalling tabs and flap |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040876A2 (en) * | 1996-04-25 | 1997-11-06 | Alfred Von Schuckmann | Inhaler |
WO1997040876A3 (en) * | 1996-04-25 | 1998-01-15 | Schuckmann Alfred Von | Inhaler |
US6401712B1 (en) | 1996-04-25 | 2002-06-11 | Astrazeneca Ab | Inhaler |
WO2001045636A1 (en) | 1999-12-20 | 2001-06-28 | Merck & Co., Inc. | Pharmaceutical kit |
US6978894B2 (en) | 1999-12-20 | 2005-12-27 | Merck & Co., Inc. | Blister package for pharmaceutical treatment card |
WO2004087038A1 (en) | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Kit for pharmaceutical use |
US7987986B2 (en) | 2007-08-06 | 2011-08-02 | Bayer Schering Pharma Ag | Device and use for storage and provision of medicament wafers |
WO2012083109A1 (en) | 2010-12-17 | 2012-06-21 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
Also Published As
Publication number | Publication date |
---|---|
GR3024935T3 (en) | 1998-01-30 |
DE69220842D1 (en) | 1997-08-21 |
ATE155340T1 (en) | 1997-08-15 |
CA2067611A1 (en) | 1992-10-30 |
EP0511726A3 (en) | 1992-12-23 |
EP0511726B1 (en) | 1997-07-16 |
ES2107499T3 (en) | 1997-12-01 |
DK0511726T3 (en) | 1998-02-09 |
DE69220842T2 (en) | 1998-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5265728A (en) | Arrangement for retaining blister pack tablets | |
US4693371A (en) | Medication dispenser and container | |
US4817819A (en) | Container for tablets | |
US6293403B1 (en) | Vitamin organizing, storing and dispensing system | |
US7128213B2 (en) | Convertible pill container | |
EP0511726B1 (en) | Arrangement for retaining blister pack tablets | |
US4905388A (en) | Organizer and reminder device for pills, medicines and the like | |
US6662081B1 (en) | Medication regimen container and system | |
US3393795A (en) | Dispensing container | |
US8936157B1 (en) | Indexing multi-compartment container-cap assembly | |
US4127190A (en) | Dispenser for dispensing pills or tablets in a predetermined order | |
US3143207A (en) | Medication dispensing means | |
US4573580A (en) | Unit dose medication dispenser | |
US20140251863A1 (en) | Push button pill container with register and methods | |
US20140251861A1 (en) | Pill container with register and push button lids and methods | |
US3738480A (en) | Medication container | |
US20140251862A1 (en) | Pill containers with registers and methods | |
US5833072A (en) | Dosage regimen container | |
AU2006286894B2 (en) | Case for accommodating a medicament pack, and use thereof | |
US3570707A (en) | Tablet dispenser | |
US5105949A (en) | Medicine and record holder | |
US3817372A (en) | Pocket pill box | |
EP0232674B1 (en) | Container for tablets | |
US7614358B2 (en) | Method and device for recording periodic medicinal dosages | |
WO2005023672A1 (en) | Dispensing apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920521 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19950322 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE |
|
REF | Corresponds to: |
Ref document number: 155340 Country of ref document: AT Date of ref document: 19970815 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69220842 Country of ref document: DE Date of ref document: 19970821 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. PATENTANWAELTE |
|
ITF | It: translation for a ep patent filed | ||
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2107499 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3024935 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 19971013 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060430 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20070308 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20070315 Year of fee payment: 16 Ref country code: DK Payment date: 20070315 Year of fee payment: 16 Ref country code: NL Payment date: 20070315 Year of fee payment: 16 Ref country code: GB Payment date: 20070315 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20070319 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20070321 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20070326 Year of fee payment: 16 Ref country code: DE Payment date: 20070326 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20070330 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20070410 Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: BERLEX LABORATORIES, INC. Free format text: BERLEX LABORATORIES, INC.#110 EAST HANOVER AVENUE#CEDAR KNOLLS, NJ 07927-2094 (US) -TRANSFER TO- BERLEX LABORATORIES, INC.#110 EAST HANOVER AVENUE#CEDAR KNOLLS, NJ 07927-2094 (US) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20070323 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20070312 Year of fee payment: 16 |
|
BERE | Be: lapsed |
Owner name: *BERLEX LABORATORIES INC. Effective date: 20080430 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20081029 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20080429 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20081101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081101 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081101 Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081029 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20081231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080429 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20080430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081104 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080429 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070429 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080429 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080430 |